Author: Michael Sumner - Page 2

Pharmacist-Led Substitution Programs: How They Work and What They Achieve

26Nov
Pharmacist-Led Substitution Programs: How They Work and What They Achieve

Pharmacist-led substitution programs reduce adverse drug events by 49%, cut hospital readmissions by up to 22%, and save $1,200-$3,500 per patient. Learn how they work, why they’re more effective than doctor-led reviews, and where they’re still lacking.

More

Machine Learning Signal Detection: How AI Is Revolutionizing Adverse Event Monitoring

25Nov
Machine Learning Signal Detection: How AI Is Revolutionizing Adverse Event Monitoring

Machine learning signal detection is transforming pharmacovigilance by spotting hidden adverse drug reactions faster and more accurately than traditional methods. Using AI on real-world data, it's reducing false alarms and catching dangers before they escalate.

More

Bioequivalence Testing for Generic Drugs: What It Really Proves

24Nov
Bioequivalence Testing for Generic Drugs: What It Really Proves

Bioequivalence testing proves generic drugs work the same as brand-name versions by matching how quickly and how much of the active ingredient enters the bloodstream. It's the science behind affordable medicine.

More

Sudden Sensorineural Hearing Loss: Why Immediate Steroid Treatment Can Save Your Hearing

23Nov
Sudden Sensorineural Hearing Loss: Why Immediate Steroid Treatment Can Save Your Hearing

Sudden sensorineural hearing loss is a medical emergency. Immediate steroid therapy within 72 hours can dramatically improve hearing recovery. Learn why time matters, how steroids work, and what to do if treatment fails.

More

CBD Products and Prescription Medications: What You Need to Know About Dangerous Interactions

22Nov
CBD Products and Prescription Medications: What You Need to Know About Dangerous Interactions

CBD can dangerously interact with prescription medications by affecting liver enzymes that process drugs. Learn which meds are risky, how to spot danger signs like grapefruit warnings, and what steps to take before using CBD.

More

Nitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts

21Nov
Nitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts

Nitrosamine contamination in generic drugs has led to over 500 FDA recalls since 2018. Learn which medications were affected, why it happened, and how regulators and manufacturers are responding to protect patient safety.

More

Multiple Sclerosis: How the Immune System Attacks the Nervous System

20Nov
Multiple Sclerosis: How the Immune System Attacks the Nervous System

Multiple sclerosis is an autoimmune disease where the immune system attacks myelin in the brain and spinal cord, causing nerve damage and symptoms like fatigue, vision loss, and numbness. Learn how it works, who’s at risk, and what treatments are changing lives.

More

GERD and Acid Reflux: How PPIs and Lifestyle Changes Work Together

20Nov
GERD and Acid Reflux: How PPIs and Lifestyle Changes Work Together

GERD and acid reflux can be managed effectively with lifestyle changes and proper use of PPIs. Learn how weight loss, diet, and timing reduce symptoms-and why long-term PPI use carries risks that can be avoided.

More

Myasthenia Gravis Treatment: Latest Therapies for Autoimmune Neuromuscular Disorder

19Nov
Myasthenia Gravis Treatment: Latest Therapies for Autoimmune Neuromuscular Disorder

Myasthenia gravis is an autoimmune disorder causing muscle weakness. Learn the latest treatments - from pyridostigmine and thymectomy to FDA-approved biologics like FcRn inhibitors - and how to navigate cost, access, and long-term management.

More

Blood Pressure Control in Kidney Disease: How ACE Inhibitors and ARBs Protect Your Kidneys

19Nov
Blood Pressure Control in Kidney Disease: How ACE Inhibitors and ARBs Protect Your Kidneys

ACE inhibitors and ARBs are first-line treatments for high blood pressure in kidney disease. They reduce proteinuria, slow kidney damage, and lower the risk of dialysis-even in advanced stages. Learn how they work, who benefits most, and why they're still underused.

More